Evidence check: TCF7L2 in the context of blood sugar

TCF7L2 is one of the most robustly replicated risk genes for type 2 diabetes. Variants such as rs7903146 (C→T) increase risk by about 1.4- to 1.5-fold per allele, primarily through impaired insulin secretion from pancreatic beta cells. Evidence comes from large GWAS and meta-analyses (e.g., 17008552, 21700256) and is considered human-strong. However, the predictive power of a single SNP is modest – lifestyle, diet, and physical activity dominate diabetes risk. A TCF7L2 test alone does not justify treatment changes. It is more useful when integrated into a polygenic risk score alongside established factors (HbA1c, fasting glucose, family history). Caveat: effect sizes vary by ancestry; most risk-allele carriers never develop diabetes.